Are Torrent Pharma latest results good or bad?
Torrent Pharmaceuticals' latest results are strong, with net sales of Rs 3,178 crore and significant growth in operating profit and net profit, marking the best performance in the last five quarters. The company shows improved financial health and profitability, reflected in a rise in earnings per share to Rs 16.19.
Torrent Pharmaceuticals has reported its financial results for the quarter ending June 2025, showcasing a notable performance across several key metrics. The company achieved net sales of Rs 3,178.00 crore, reflecting a quarter-on-quarter growth of 7.40% compared to the previous quarter. This marks the highest quarterly sales in recent history for the company.The operating profit (PBDIT) also demonstrated a positive trend, totaling Rs 1,032.00 crore, which indicates a growth of 7.05% from the prior quarter. Additionally, the profit before tax (PBT) reached Rs 775.00 crore, while the profit after tax (PAT) amounted to Rs 548.00 crore, both representing the best figures in the last five quarters.
Earnings per share (EPS) rose to Rs 16.19, reflecting the company's focus on enhancing profitability and providing higher returns to shareholders. The operating profit to interest ratio stood at 18.43 times, the highest in the last five quarters, indicating improved management of interest payments.
Overall, Torrent Pharmaceuticals continues to exhibit strong financial health and operational success within the competitive pharmaceuticals and biotechnology sector. Furthermore, the company saw an adjustment in its evaluation following these results.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
